TANG KEVIN purchased 7.6% of their position (284.14K shares) of RAIN ONCOLOGY INC. on the open market
Open‑market purchase worth $279.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 10/13/2023ACC: 0001209191-23-052788
+284.14K
Net shares
Net buyer
$279.0K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
284.14K acquired
Non-Derivative Transactions5
Common Stock
Indirect
Shares
+74.81K
Price / share
$0.97
Trade value
$72.57K
% of position
2.0%
10/11/2023
3.74M→3.82M
Common Stock
Indirect
Shares
+25.19K
Price / share
$0.98
Trade value
$24.68K
% of position
0.7%
10/12/2023
3.82M→3.84M
Common Stock
Indirect
Shares
+52.51K
Price / share
$0.98
Trade value
$51.46K
% of position
1.4%
10/12/2023
3.84M→3.89M
Common Stock
Indirect
Shares
+47.49K
Price / share
$0.99
Trade value
$47.01K
% of position
1.2%
10/13/2023
3.89M→3.94M
Common Stock
Indirect
Shares
+84.14K
Price / share
$0.99
Trade value
$83.30K
% of position
2.1%
10/13/2023
3.94M→4.02M
Total
Net shares
+284.14K
Net value
$279.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/11/2023 | P · Purchase | +74.81K | $0.97 | $72.57K | 2.0% | 3.74M | 3.82M |
| Common Stock Indirect | 10/12/2023 | P · Purchase | +25.19K | $0.98 | $24.68K | 0.7% | 3.82M | 3.84M |
| Common Stock Indirect | 10/12/2023 | P · Purchase | +52.51K | $0.98 | $51.46K | 1.4% | 3.84M | 3.89M |
| Common Stock Indirect | 10/13/2023 | P · Purchase | +47.49K | $0.99 | $47.01K | 1.2% | 3.89M | 3.94M |
| Common Stock Indirect | 10/13/2023 | P · Purchase | +84.14K | $0.99 | $83.30K | 2.1% | 3.94M | 4.02M |
| Total | +284.14K | $279.03K | ||||||
Derivative Transactions0
No derivative transactions reported